Clinical Trial Update: Efficacy and Safety of Sitagliptin/Metformin Fixed-Dose Combination (FDC) Compared to Glimepiride in Participants With Type 2 Diabetes Mellitus (MK-0431A-202) [Phase 4]

View source ↗

Summary

Phase 4 trial comparing sitagliptin/metformin fixed-dose combination to glimepiride in adults with type 2 diabetes mellitus; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Glimepiride (glimepiride)
• Januvia/metformin fixed-dose combination (sitagliptin/metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2014-09-15